We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBER icon
201
Uber
UBER
$144B
$2.45M 0.17%
33,690
-24,510
-42% -$1.77M
SYM icon
202
Symbotic
SYM
$5.39B
$2.44M 0.17%
120,937
+73,397
+154% +$1.87M
CALY
203
Callaway Golf Company
CALY
$3.28B
$2.43M 0.17%
369,390
+358,466
+3,281% +$2.63M
GM icon
204
General Motors
GM
$81.7B
$2.43M 0.17%
+51,600
New +$2.54M
TJX icon
205
TJX Companies
TJX
$178B
$2.43M 0.17%
+19,911
New +$2.42M
WAT icon
206
Waters Corp
WAT
$37.7B
$2.4M 0.17%
+6,503
New +$2.52M
POST icon
207
Post Holdings
POST
$4.27B
$2.39M 0.17%
+20,520
New +$2.28M
SOBO
208
South Bow Corp
SOBO
$7.75B
$2.37M 0.17%
92,989
+82,575
+793% +$2.07M
WTS icon
209
Watts Water Technologies
WTS
$11.6B
$2.35M 0.17%
11,524
-2,066
-15% -$433K
PARR icon
210
Par Pacific Holdings
PARR
$3.97B
$2.35M 0.17%
+164,621
New +$2.58M
DYN icon
211
Dyne Therapeutics
DYN
$4.28B
$2.34M 0.17%
+224,176
New +$3.21M
ALHC icon
212
Alignment Healthcare
ALHC
$3.81B
$2.34M 0.17%
125,576
+44
+0% +$656
UDMY
213
DELISTED
Udemy
UDMY
$2.33M 0.17%
300,653
+235,575
+362% +$2M
AGNT
214
AGNT Inc
AGNT
$661M
$2.33M 0.17%
238,087
+185,195
+350% +$1.97M
ZTS icon
215
Zoetis
ZTS
$32.5B
$2.31M 0.16%
14,003
-24,864
-64% -$4.13M
PGY icon
216
Pagaya Technologies
PGY
$1.38B
$2.29M 0.16%
218,168
+182,177
+506% +$2.02M
BSX icon
217
Boston Scientific
BSX
$68.5B
$2.28M 0.16%
22,600
+19,075
+541% +$1.92M
MXL icon
218
MaxLinear
MXL
$5.35B
$2.27M 0.16%
209,227
+23,579
+13% +$394K
SPNT icon
219
SiriusPoint
SPNT
$3.09B
$2.25M 0.16%
130,186
-40
-0% -$596
SMTC icon
220
Semtech
SMTC
$10.4B
$2.25M 0.16%
65,366
+25,098
+62% +$1.24M
STEP icon
221
StepStone Group
STEP
$3.65B
$2.25M 0.16%
43,017
HBAN icon
222
Huntington Bancshares
HBAN
$35B
$2.24M 0.16%
149,200
MNDY icon
223
monday.com
MNDY
$3.68B
$2.23M 0.16%
9,187
+4
+0% +$1.06K
SMG icon
224
ScottsMiracle-Gro
SMG
$4.25B
$2.22M 0.16%
40,503
-5,201
-11% -$336K
TNET icon
225
TriNet
TNET
$3.14B
$2.2M 0.16%
+27,788
New +$2.31M

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.